MCK

Prezzo Mckesson Corp

MCK
$862,35
-$4,99(-0,57%)

*Data last updated: 2026-04-17 13:41 (UTC+8)

As of 2026-04-17 13:41, Mckesson Corp (MCK) is priced at $862,35, with a total market cap of $107,05B, a P/E ratio of 26,02, and a dividend yield of 0,36%. Today, the stock price fluctuated between $861,50 and $867,34. The current price is 0,09% above the day's low and 0,57% below the day's high, with a trading volume of 370,18K. Over the past 52 weeks, MCK has traded between $845,44 to $887,25, and the current price is -2,80% away from the 52-week high.

MCK Key Stats

Yesterday's Close$863,42
Market Cap$107,05B
Volume370,18K
P/E Ratio26,02
Dividend Yield (TTM)0,36%
Dividend Amount$0,82
Diluted EPS (TTM)35,22
Net Income (FY)$3,29B
Revenue (FY)$359,05B
Earnings Date2026-05-07
EPS Estimate11,56
Revenue Estimate$101,28B
Shares Outstanding123,98M
Beta (1Y)0.423
Ex-Dividend Date2026-03-02
Dividend Payment Date2026-04-01

About MCK

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
SectorHealthcare
IndustryMedical - Distribution
CEOBrian S. Tyler
HeadquartersIrving,TX,US
Official Websitehttps://www.mckesson.com
Employees (FY)45,00K
Average Revenue (1Y)$7,97M
Net Income per Employee$73,22K

Mckesson Corp (MCK) FAQ

What's the stock price of Mckesson Corp (MCK) today?

x
Mckesson Corp (MCK) is currently trading at $862,35, with a 24h change of -0,57%. The 52-week trading range is $845,44–$887,25.

What are the 52-week high and low prices for Mckesson Corp (MCK)?

x

What is the price-to-earnings (P/E) ratio of Mckesson Corp (MCK)? What does it indicate?

x

What is the market cap of Mckesson Corp (MCK)?

x

What is the most recent quarterly earnings per share (EPS) for Mckesson Corp (MCK)?

x

Should you buy or sell Mckesson Corp (MCK) now?

x

What factors can affect the stock price of Mckesson Corp (MCK)?

x

How to buy Mckesson Corp (MCK) stock?

x

Risk Warning

The stock market involves a high level of risk and price volatility. The value of your investment may increase or decrease, and you may not recover the full amount invested. Past performance is not a reliable indicator of future results. Before making any investment decisions, you should carefully assess your investment experience, financial situation, investment objectives, and risk tolerance, and conduct your own research. Where appropriate, consult an independent financial adviser.

Disclaimer

The content on this page is provided for informational purposes only and does not constitute investment advice, financial advice, or trading recommendations. Gate shall not be held liable for any loss or damage resulting from such financial decisions. Further, take note that Gate may not be able to provide full service in certain markets and jurisdictions, including but not limited to the United States of America, Canada, Iran, and Cuba. For more information on Restricted Locations, please refer to the User Agreement.

Other Trading Markets

Hot Posts su Mckesson Corp (MCK)

SelfRugger

SelfRugger

10 ore fa
Is Wall Street Bullish or Bearish on McKesson Stock? ==================================================== Mckesson Corporation logo on building-by JHVEPhoto via iStock Anushka Mukherjee Wed, February 18, 2026 at 12:43 AM GMT+9 2 min read In this article: * StockStory Top Pick MCK +1.31% * ^GSPC +0.38% Irving, Texas-based McKesson Corporation (MCK) distributes pharmaceuticals, medical-surgical supplies and health and beauty care products principally in North America. Valued at a market cap of $114.5 billion, the company operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The company's shares have outperformed the broader market over the past year and in 2026. MCK stock has grown 55.2% over the past 52 weeks and 14% on a YTD basis. In comparison, the S&P 500 Index ($SPX) has returned 11.8% over the past year and declined marginally in 2026. ### More News from Barchart * Calm Waters for Alphabet (GOOG, GOOGL) Stock Present a Tempting Options Trade * Amazon Put Options at Lower Strike Prices Have High Yields * Is GOOG Stock a Buy Amid the Software Selloff? * Markets move fast. Keep up by reading our FREE midday Barchart Brief newsletter for exclusive charts, analysis, and headlines. Narrowing the focus, MCK has also outperformed the State Street Healthcare Select Sector SPDR ETF’s (XLV), 7.7% rise over the past 52 weeks. www.barchart.com On Feb. 5, MCK shares surged 16.5% following the release of its better-than-expected Q3 2026 earnings. The company’s revenue increased 11.4% year-over-year to $106.2 billion, in line with the Street’s expectations. Moreover, its adjusted EPS amounted to $9.34, successfully surpassing Wall Street estimates. McKesson expects full-year earnings in the range of $38.80 to $39.20 per share. For the current year, ending in March 2026, analysts expect MCK’s EPS to grow 18.1% YoY to $39.03 on a diluted basis. The company’s earnings surprise history is strong. It beat the consensus estimates in each of the last four quarters. Among the 17 analysts covering MCK stock, the consensus is a “Strong Buy.” That’s based on 13 “Strong Buy” ratings and four “Holds.” www.barchart.com On Feb. 10, JP Morgan analyst Lisa Gill maintained an "Overweight" rating on McKesson and raised its price target from $983 to $1107. The mean price target of $965.56 indicates a 3.3% premium to MCK’s current price levels. Its Street-high target of $1,107 suggests a 18.4% potential upside. _ On the date of publication, Anushka Mukherjee did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Barchart.com _ Terms and Privacy Policy Privacy Dashboard More Info
0
0
0
0